Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Myasthenia Gravis × Clear all

NCT07243366 2025-11-21

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

Phase EARLY_PHASE1 Not yet recruiting

Myasthenia Gravis